Company Filing History:
14 out of 16 
2 out of 2 
2 out of 5 Years Active: 1997-2021
Title: Innovation and Impact: The Contributions of Daniel H. Zimmerman
Introduction
Daniel H. Zimmerman, based in Bethesda, MD, is a prolific inventor recognized for his significant contributions to the field of biotechnology with 18 patents to his name. His groundbreaking work focuses on peptide constructs and their applications in treating autoimmune diseases and viral infections, particularly rheumatoid arthritis and Type A influenza.
Latest Patents
Zimmerman's latest innovations include two major patents. The first patent details the methods of preparation and composition of peptide constructs that are useful for treating rheumatoid arthritis (RA). These constructs consist of polypeptides linked together to target specific T cells associated with autoimmune diseases and provoke an immune response without causing a full activation. The formula P-x-P represents these constructs, with P denoting a peptide linked to autoimmune responses and x functioning as a covalent bond or linker.
The second patent involves a method for inducing an immune response against various influenza viruses, including H1N1 and H5N9. This patent describes an immunologically effective vaccine formulated from peptide constructs that target conserved proteins of the Type A influenza virus. The P-x-P formula is also utilized here, with the constructs designed to evoke a targeted immune response by engaging with T cells or dendritic cells in an efficient manner.
Career Highlights
Throughout his career, Daniel H. Zimmerman has worked with notable companies in the biotech industry, including Cel-Sci Corporation and Cell Med, Inc. His innovative spirit and dedication to research have resulted in numerous advancements in medical treatments, particularly in immunology and autoimmune disorders.
Collaborations
Zimmerman has collaborated with esteemed coworkers, including Prem S. Sarin and Ellis L. Kline, enhancing his research through shared expertise and insights. These partnerships have played a crucial role in paving the way for novel therapeutic approaches and refining existing methodologies in the field.
Conclusion
Daniel H. Zimmerman's contributions to the field of biotechnology are profound and impactful. With a focus on peptide constructs and their therapeutic applications, his patents represent significant advancements in the treatment of autoimmune diseases and infectious viruses. Through his career and collaborations, Zimmerman continues to inspire innovation and progress in medical science.